Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Heart Transplantation | 8 | 2020 | 1293 | 0.87 | Why? |
| Heart-Assist Devices | 3 | 2017 | 812 | 0.54 | Why? |
| Defibrillators, Implantable | 2 | 2017 | 624 | 0.50 | Why? |
| Propensity Score | 1 | 2016 | 2690 | 0.35 | Why? |
| Cardiovascular Diseases | 4 | 2020 | 11497 | 0.25 | Why? |
| Electrocardiography | 4 | 2020 | 3957 | 0.24 | Why? |
| Heart Failure | 3 | 2020 | 6638 | 0.23 | Why? |
| Troponin T | 3 | 2020 | 771 | 0.21 | Why? |
| Allografts | 3 | 2018 | 761 | 0.20 | Why? |
| Angina Pectoris, Variant | 1 | 2018 | 3 | 0.19 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.18 | Why? |
| Pericarditis | 2 | 2020 | 417 | 0.17 | Why? |
| Primary Graft Dysfunction | 1 | 2017 | 44 | 0.17 | Why? |
| Antibodies, Anti-Idiotypic | 1 | 2017 | 93 | 0.17 | Why? |
| Registries | 1 | 2016 | 12327 | 0.16 | Why? |
| Transplantation, Homologous | 1 | 2018 | 757 | 0.14 | Why? |
| Coronary Vessels | 2 | 2018 | 914 | 0.13 | Why? |
| Shock, Cardiogenic | 1 | 2020 | 700 | 0.13 | Why? |
| Coronary Angiography | 2 | 2020 | 2275 | 0.12 | Why? |
| Heart Ventricles | 1 | 2020 | 1139 | 0.11 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.11 | Why? |
| Heart Rate | 1 | 2020 | 1527 | 0.11 | Why? |
| Postoperative Complications | 3 | 2020 | 5861 | 0.11 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.11 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.11 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.10 | Why? |
| Atrial Fibrillation | 2 | 2020 | 2320 | 0.10 | Why? |
| New York | 1 | 2016 | 2488 | 0.09 | Why? |
| Fibrinolytic Agents | 1 | 2020 | 1702 | 0.09 | Why? |
| Tissue Donors | 1 | 2018 | 1679 | 0.09 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.08 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.08 | Why? |
| Echocardiography | 1 | 2020 | 3661 | 0.08 | Why? |
| B-Lymphocytes | 2 | 2017 | 4418 | 0.07 | Why? |
| Follow-Up Studies | 3 | 2020 | 17020 | 0.07 | Why? |
| Cardiology | 1 | 2020 | 2873 | 0.07 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.06 | Why? |
| New York City | 3 | 2020 | 7432 | 0.06 | Why? |
| Survival Rate | 1 | 2016 | 9206 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Diagnosis, Differential | 3 | 2020 | 7220 | 0.05 | Why? |
| Glycosaminoglycans | 1 | 2020 | 140 | 0.05 | Why? |
| Intra-Aortic Balloon Pumping | 1 | 2020 | 125 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.05 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Hyperlipidemias | 1 | 2020 | 290 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2020 | 219 | 0.04 | Why? |
| Humans | 16 | 2020 | 930598 | 0.04 | Why? |
| Pulsatile Flow | 1 | 2017 | 123 | 0.04 | Why? |
| Ventricular Function, Right | 1 | 2020 | 388 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Middle Aged | 9 | 2020 | 270681 | 0.04 | Why? |
| Angiography | 1 | 2017 | 301 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Plasma Cells | 1 | 2017 | 464 | 0.03 | Why? |
| Hemostasis | 1 | 2020 | 811 | 0.03 | Why? |
| Cardiovascular Agents | 1 | 2020 | 663 | 0.03 | Why? |
| Male | 9 | 2020 | 367725 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Female | 9 | 2020 | 380317 | 0.03 | Why? |
| Time Factors | 1 | 2016 | 31397 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Cardiac Catheterization | 1 | 2020 | 882 | 0.03 | Why? |
| Receptors, Interleukin-6 | 1 | 2020 | 1383 | 0.03 | Why? |
| Biomarkers | 3 | 2020 | 23361 | 0.03 | Why? |
| Immunosuppressive Agents | 2 | 2020 | 6331 | 0.03 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.03 | Why? |
| Ventricular Function, Left | 1 | 2020 | 1555 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Adult | 5 | 2020 | 244371 | 0.03 | Why? |
| Stroke Volume | 1 | 2020 | 2153 | 0.03 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2020 | 1671 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Waiting Lists | 1 | 2017 | 1388 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Acute Coronary Syndrome | 1 | 2020 | 2107 | 0.02 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.02 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.02 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.01 | Why? |
| Kidney Transplantation | 1 | 2020 | 5397 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.01 | Why? |
| Aged | 3 | 2020 | 215776 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.01 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
Clerkin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(118)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(150)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_